Abstract
Testing antilaminaribioside (ALCA) and antichitobioside (ACCA) antibodies in 89 Crohn’s disease (CD), 31 ulcerative colitis (UC) and 50 controls, mean values were 38.6 and 53.0 ELISA units for CD, 34.0 and 32.6 for UC, 34.5 and 36.4 for controls, respectively. There was no significant difference of ALCA values between CD and UC (p = 0.401), CD and control subjects (p = 0.698) or UC and controls (p = 0.898). ACCA were significantly higher in CD compared with UC (p = 0.011) but not with the controls (p = 0.095). No significant difference of ACCA values between UC and controls (p = 0.107) was found. ALCA and ACCA values significantly correlated in CD (r = 0.548, p < 10−4) and UC (r = 0.885, p < 10−4) but not in controls (r = 0.153, p = 0.287). The positive predictive value for CD was only 20 (ALCA) and 8 % (ACCA), the negative ones (to exclude CD) 25 (ALCA) and 86 % (ACCA). Small and/or large bowel involvement or disease type (i.e. stenosing, perforating or inflammatory) of CD did not differ in the two values. The idea that ALCA and ACCA may be useful either to differentiate between CD, UC and healthy subjects or to stratify CD was not confirmed.
Similar content being viewed by others
Abbreviations
- ACCA:
-
antichitobioside antibodies
- EU:
-
ELISA unit
- ALCA:
-
antilaminaribioside antibodies
- IBD:
-
inflammatory bowel disease
- AMCA:
-
antimannobioside antibodies
- pANCA:
-
antineutrophil cytoplasmic antibodies
- ASCA:
-
anti-Saccharomyces cerevisiae antibodies
- UC:
-
ulcerative colitis
- CD:
-
Crohn’s disease
References
Altstock R.T., Shtevi A., Karban A., Dotan N., Halpern Z., Dotan I.: Improved IBD diagnosis via ELISA detecting novel antibodies: antichitobioside carbohydrate antibodies (ACCA), antilaminaribioside carbohydrate antibodies (ALCA) and antimannobioside carbohydrate antibodies (AMCA). Gastroenterology 128, A303 (2005).
Dotan I., Fishman S., Kariv R., Dgani Y., Schwartz M., Gargir A., Spector L., Altstock R., Halpern Z., Dotan N.: Antilaminarobioside carbohydrate antibodies (ALCA) and antichitobiose carbohydrate antibodies (ACCA) are novel serologic markers specific for Crohn’s disease. Gastroenterology 125(Suppl. 2), A203 (2004).
Dotan I., Fishman S., Dgani Y., Schwartz M., Karban A., Lerner A., Weishauss O., Spector L., Shtevi A., Altstock R.T., Dotan N., Halpern Z.: Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn’s disease. Gastroenterology 131, 366–378 (2006).
Ferrante M., Henckaerts L., Joossens M., Pierik M., Joossens S., Dotan N., Norman G., Altstock R., Van Steen K., Rutgeerts P., Van Assche G., Vermeire S.: New serological markers in inflammatory bowel disease are associated with complicated disease behavior. Gut 56, 1394–1403 (2007).
Glycominds: IBDX ALCA IgG kit and IBDX ACCA IgA kit. Instructions for Use, version 06. Glycominds Ltd., Lod (Israel) 2006.
Lawrance I.C., Murray K., Hall A., Sung J.J., Leong R.: A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am.J.Gastroenterol. 99, 2186–2194 (2004).
Main J., Mckenzie H., Kerr M.A., Robson D., Pennigton C.R., Parrat D.: Antibody to Sacharomyces cerevisiae (bakers’ yeast) in Crohn’s disease. Brit.Med.J. 297, 1105 (1998).
Malíčková K., Lukáš M., Donoval R., Šandová P., Janatková I.: Novel anti-carbohydrate autoantibodies in patients with inflammatory bowel disease: are they useful for clinical practice? Clin.Lab. 52, 631–638 (2006).
Peeters M., Joossens S., Vermeire S., Vlietinck R., Bossuyt X., Rutgeerts P.: Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am.J.Gastroenterol. 96, 730–734 (2001).
Peppercon M.A.: Clinical manifestation and diagnosis of Crohn’s disease in adults. UpToDate, Vol. 15.3. Wellesley (2007); http://www.uptodate.com/ .
Ruemmele F.M., Targan S.R., Levy G., Dubinsky M., Braun J., Seidman E.G.: Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology 115, 822–829 (1998).
Vermeire S., Joossens S., Peeters M., Monsuur F., Marien G., Bossuyt X., Groenen P., Vlietinck R., Rutgeerts P.: Comparative study of ASCA (anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 120, 827–833 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rejchrt, S., Drahošová, M., Kopáčová, M. et al. Antilaminaribioside and antichitobioside antibodies in inflammatory bowel disease. Folia Microbiol 53, 373–376 (2008). https://doi.org/10.1007/s12223-008-0058-2
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-008-0058-2